摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tert-butyl-N-furan-3-ylmethylamine | 1027904-74-0

中文名称
——
中文别名
——
英文名称
N-tert-butyl-N-furan-3-ylmethylamine
英文别名
N-(furan-3-ylmethyl)-2-methylpropan-2-amine
N-tert-butyl-N-furan-3-ylmethylamine化学式
CAS
1027904-74-0
化学式
C9H15NO
mdl
——
分子量
153.224
InChiKey
AQHBVQVKVWXNPK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    184.7±15.0 °C(Predicted)
  • 密度:
    0.937±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    25.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Additive and Vinylogous Pummerer Reactions of Amido Sulfoxides and Their Use in the Preparation of Nitrogen Containing Heterocycles
    摘要:
    The alpha-thiocarbocation generated from the Pummerer re action of N-methyl-N-phenyl-2-[2-(toluene-4-sulfinyl)phenyl]acetamide undergoes Friedel-Crafts reaction at the gamma-carbon with the tethered aromatic ring. Reductive removal of the phenylthio group from the resulting product using Raney nickel occurs in high yield, and the overall reaction represents a new method for the synthesis of a variety of 3-phenyl-substituted oxindoles. Treatment of the related N-benzyl-N-alkyl amido sulfoxide system with trifluoroacetic anhydride affords tetrahydroisoquinolone derivatives. The product distribution encountered coincides with the rotamer population of the starting amide. When the N-benzyl-N-methyl amide is used, only the normal Pummerer product is formed. In this case, the thionium ion is generated in the wrong conformation for pi-cyclization to occur. The corresponding N-tert-butyl amido system, however, exists in a geometric orientation which places the benzylic group in the crucial conformation necessary for pi-cyclization, and consequently, the reaction proceeds smoothly. Related cyclization reactions occur in good yield with the corresponding furanyl and cyclohexenyl N-tert-butyl amido sulfoxides. The additive Pummerer reaction of 3-phenylsulfinyl-N-benzyl-N-tert-butylacrylamide gave products derived from both 5- and 6-exo trig cyclizations. Intramolecular electrophilic aromatic substitution via six-membered ring closure ultimately afforded a dihydropyridone. The competitive process involving ipso attack of the aromatic ring on the thionium ion generates a spiro cyclohexadienyl cation that undergoes fragmentation of the adjacent a-bond. The resulting acyl iminium ion is converted to N-tert-butyl-2-phenyl-3-phenylsulfinylacrylamide upon aqueous workup. Only cyclizations leading to five-membered rings occur with the corresponding indolyl and alkenyl N-tert-butyl amido sulfoxides.
    DOI:
    10.1021/jo972093h
  • 作为产物:
    描述:
    3-呋喃甲醇三溴化磷 作用下, 以 四氢呋喃 为溶剂, 反应 21.0h, 生成 N-tert-butyl-N-furan-3-ylmethylamine
    参考文献:
    名称:
    溴氧化反应制得的3-糠基胺中的3-甲酰基吡咯
    摘要:
    在丙酮-水溶液中用溴氧化3-糠胺3a-e得到高收率的N-取代的3-甲酰基吡咯4a-e。提出了通过Clauson-Kaas反应的反应机理,然后通过2-烯-1,4-二酮13和14的顺反异构化来解释吡咯4a-e的形成。
    DOI:
    10.1002/jccs.201000195
点击查看最新优质反应信息

文献信息

  • Access to β-Lactams by Enantioselective Palladium(0)-Catalyzed C(sp<sup>3</sup>)H Alkylation
    作者:Julia Pedroni、Michele Boghi、Tanguy Saget、Nicolai Cramer
    DOI:10.1002/anie.201405508
    日期:2014.8.18
    Reported here is an asymmetric CH functionalization approach to β‐lactams using readily accessible chloroacetamide substrates. Important aspects of this transformation are challenging C(sp3)C(sp3) and strain‐building reductive eliminations to for the four‐membered ring. In general, the β‐lactams are formed in excellent yields and enantioselectivities using a bulky taddol phosphoramidite ligand in combination
    β-内酰胺由于具有广泛的生物学活性以及易于发生开环反应,因此是非常重要的结构基序。过渡属催化的CH功能化已成为实现非常规高效断开连接的策略。与Pd 0催化的CH官能化用于芳基-芳基偶联的显着进展相反,涉及形成饱和C(sp 3)C(sp 3)键的相关反应是难以捉摸的。这里报告的是一个不对称的C使用容易获得的乙酰胺底物对β-内酰胺进行H官能化方法。这种转变的重要方面是挑战四元环的C(sp 3)C(sp 3)和应变消除。通常,使用大体积的他达酰胺配体金刚烷羧酸作为助催化剂,可以以优异的收率和对映选择性形成β-内酰胺。
  • TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20160152628A1
    公开(公告)日:2016-06-02
    The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    本发明提供了式(I)的化合物:或其立体异构体,互变异构体或药学上可接受的盐,其中所有变量如本文所定义。这些化合物是选择性ROCK抑制剂。本发明还涉及包含这些化合物的制药组合物以及使用它们治疗心血管,平滑肌,肿瘤,神经病理,自身免疫,纤维化和/或炎症性疾病的方法。
  • Indolone compounds and their use as AMPA receptor modulators
    申请人:Janssen Pharmaceutica NV
    公开号:US10604484B2
    公开(公告)日:2020-03-31
    Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions, comprising compounds of Formula (I), and methods of using compounds of Formula (I).
    本文提供的是式 (I) 化合物及其药学上可接受的盐、N-氧化物或溶解物、 本文还提供了包含式(I)化合物的药物组合物,以及使用式(I)化合物的方法。
  • METHODS, COMPOUNDS, AND COMPOSITIONS FOR REDUCING BODY FAT AND MODULATING FATTY ACID METABOLISM
    申请人:Piomelli Daniele
    公开号:US20090005447A1
    公开(公告)日:2009-01-01
    Methods, pharmaceutical compositions, and compounds for reducing body weight, modulating body lipid metabolism, and reducing food intake in mammals are provided. The compounds of the invention include fatty acid ethanolamide compounds, homologues and analogs of which the prototype is the endogenous fatty acid ethanolamide, oleoylethanolamide.
  • INDOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS
    申请人:Janssen Pharmaceutica NV
    公开号:US20180118683A1
    公开(公告)日:2018-05-03
    Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, Also provided herein are pharmaceutical compositions, comprising compounds of Formula (I), and methods of using compounds of Formula (I).
查看更多

同类化合物

(乙腈)二氯镍(II) (R)-(-)-α-甲基组胺二氢溴化物 (N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-3-氨基环丁烷甲腈盐酸盐 顺式-2-羟基甲基-1-甲基-1-环己胺 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺二盐酸盐 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷